Cite
HARVARD Citation
Bettelli, S. et al. (2021). Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting. Leukemia research. p. . [Online].